Related content

Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer

By                          

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 719-724

Spandidos Publications

Access to resources Recommend Favorite

Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients

By Brosens R.  

Cellular Oncology, Vol. 34, Iss. 3, 2011-06 ,pp. : 215-223

Springer Publishing Company

Access to resources Recommend Favorite

MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia

By Yokoyama A.   Yamashita T.   Shiozawa E.   Nagasawa A.   Okabe-Kado J.   Nakamaki T.   Tomoyasu S.   Kimura F.   Motoyoshi K.   Honma Y.   Kasukabe T.  

Leukemia Research, Vol. 28, Iss. 2, 2004-02 ,pp. : 149-157

Elsevier

Access to resources Recommend Favorite

High expression of peroxiredoxin 4 affects the survival time of colorectal cancer patients, but is not an independent unfavorable prognostic factor

By            

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 767-772

Spandidos Publications

Access to resources Recommend Favorite

Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma

By  

Current Molecular Medicine, Vol. 17, Iss. 10, 2018-05 ,pp. : 707-717

Bentham Science Publishers

Access to resources Recommend Favorite